Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Biochimica Et Biophysica Acta. Reviews on Cancer|April 2, 2023
Vestigial-like 1 (VGLL1): An ancient co-transcriptional activator linking wing, placenta, and tumor developmentHeather M Sonnemann, Barbara Pazdrak, Dinler A Antunes, et al.Frontiers in Oncology|June 24, 2024
Placental co-transcriptional activator Vestigial-like 1 (VGLL1) drives tumorigenesis via increasing transcription of proliferation and invasion genesHeather M Sonnemann, Barbara Pazdrak, Barbara Nassif, et al.Journal for Immunotherapy of Cancer|June 13, 2018
Dexamethasone-induced immunosuppression: mechanisms and implications for immunotherapyAmber J Giles, Marsha-Kay N D Hutchinson, Heather M Sonnemann, et al.Frontiers in Oncology|August 2, 2021
Reversing Epigenetic Gene Silencing to Overcome Immune Evasion in CNS MalignanciesNivedita M Ratnam, Heather M Sonnemann, Stephen C Frederico, et al.PNAS Nexus|August 25, 2022
Charge-based interactions through peptide position 4 drive diversity of antigen presentation by human leukocyte antigen class I moleculesKyle R Jackson, Dinler A Antunes, Amjad H Talukder, et al.Nature Communications|October 22, 2020
Vestigial-like 1 is a shared targetable cancer-placenta antigen expressed by pancreatic and basal-like breast cancersSherille D Bradley, Amjad H Talukder, Ivy Lai, et al.Journal for Immunotherapy of Cancer|July 10, 2021
Neoantigen vaccination induces clinical and immunologic responses in non-small cell lung cancer patients harboring EGFR mutationsFenge Li, Ligang Deng, Kyle R Jackson, et al.Pageof 1